This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cancer Research Technology Limited, King's College London. Active years: 2017-2019.
Company Filing History:
2 out of 268 
1 out of 195 
Years Active: 2017-2019
Title: Joerg Bartsch: Innovator in ADAM Protease Inhibition
Introduction
Joerg Bartsch is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the area of protease inhibition. With a total of 2 patents, his work focuses on innovative methods that have potential applications in pharmaceuticals.
Latest Patents
Bartsch's latest patents include a method for inhibiting ADAM proteases with cyclic peptides. This invention relates to a method for inhibiting an ADAM protease by preventing binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Additionally, he has developed cyclic peptides that serve as inhibitors of ADAM proteases, along with associated pharmaceutical compositions, uses, and methods of treatment.
Career Highlights
Throughout his career, Joerg Bartsch has worked with prominent organizations such as Cancer Research Technology Limited and King's College London. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Garrit Koller. Their partnership has likely fostered innovative ideas and advancements in their shared field of research.
Conclusion
Joerg Bartsch's contributions to the field of protease inhibition through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical applications.